The role of HLA-Class Ib molecules in immune-related diseases, tumors, and infections by Morandi, Fabio et al.
Editorial
The Role of HLA-Class Ib Molecules in Immune-Related
Diseases, Tumors, and Infections
Fabio Morandi,1 Enrico Fainardi,2 Roberta Rizzo,3 and Nathalie Rouas-Freiss4
1 Laboratory of Oncology, Istituto Giannina Gaslini, Via Gerolamo Gaslini, No. 5, 16147 Genova, Italy
2 Neuroradiology Unit, Department of Neurosciences and Rehabilitation, Azienda Ospedaliera-Universitaria, Arcispedale S. Anna,
Via Aldo Moro, No. 8, Cona, 44124 Ferrara, Italy
3 Department of Experimental and Diagnostic Medicine, Section of Microbiology, University of Ferrara, Via Savonarola, No. 9,
44121 Ferrara, Italy
4CEA, Institut des Maladies E´mergentes et des The´rapies Innovantes (iMETI), Service de Recherche en He´mato-Immunologie (SRHI),
Hoˆpital Saint-Louis, Avenue Claude Vellefaux 1, 75010 Paris, France
Correspondence should be addressed to Fabio Morandi; fabiomorandi@ospedale-gaslini.ge.it
Received 7 April 2014; Accepted 7 April 2014; Published 28 May 2014
Copyright © 2014 Fabio Morandi et al.This is an open access article distributed under the Creative Commons Attribution License,
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
HLA-class Ib family include HLA-E, -F, -G, and -H mole-
cules that, in contrast with high polymorphic HLA-class Ia
molecules (HLA-A, -B, and -C), display a limited polymor-
phism, with a small number of alleles encoding limited
functional proteins. Similar to HLA-class Ia molecules, HLA-
class Ib molecules bind peptides generated from cytosolic
antigens and present them to CD8+ T lymphocytes, but their
main function is the regulation of immune responses, both in
physiological and pathological conditions.
HLA-G, the best characterized HLA-Ib molecule, is
expressed on fetal cytotrophoblast cells during pregnancy and
abrogates maternal NK cell cytotoxicity against fetal tissues.
However, HLA-G is also expressed (or released as soluble
molecules) by different cells and tissues in pathological
contexts such as tumors, grafted organs, pathogen-infected
cells, and inflammatory tissues.HLA-G interactswith specific
receptors on T and B lymphocytes, NK cells, neutrophils, and
antigen presenting cells, inhibiting their function. HLA-E is
virtually expressed by all nucleated cells and binds peptides
derived from HLA-class I molecules leader sequence. In
physiological conditions, it interacts with CD94/NKG2A
inhibitory receptor on NK cells, inhibiting their cytotoxi-
city against cells displaying normal HLA-class I molecules
expression. When such molecules are downregulated (i.e.,
transformed or infected cells), HLA-class I-derived peptides
are lower and subsequently HLA-E expression is dampened,
allowing NK cells lo lyse these cells. However, different
transformed cells upregulate HLA-E expression to avoid NK-
cell mediated lysis. Limited information is available regarding
HLA-F function. This molecule acts as chaperone for the
𝛽2-microglobulin-free heavy chain of other HLA-class I
molecules, and it is expressed on the surface of activated lym-
phocytes. So far, no functional HLA-Hmolecules encoded by
HLA-H genes have been characterized.
In the present issue dedicated to these nonclassical HLA-
class Ib molecules, two papers have analyzed some basic
aspects of HLA-G. First, E. C. Castelli et al. have reviewed
some interesting data regarding the regulation of HLA-G
gene expression. They analyzed different mechanisms that
operate at transcriptional and posttranscriptional level, with
emphasis on polymorphisms that are present both in the
untranslated and coding region. Second, E. Alegre et al. have
described the factors involved in the generation of different
HLA-G isoforms. Moreover, the authors analyzed the data
present in the literature regarding posttranslationalmodifica-
tions ofHLA-Gmolecules and the expression and function of
different HLA-G specific receptors.
The murine homologue of HLA-G and –E and Qa2 and
Qa1 has been analyzed by B. L. Melo-Lima et al., who have
provided some interesting data regarding the expression of
these molecules during fetal and postnatal development of
thymus and other tissues.
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Three papers have explored the role of HLA-G in physio-
logical conditions. The review by M. Dahl et al. has analyzed
factors that regulate HLA-G expression during pregnancy,
with emphasis on differential spatiotemporal expression of
HLA-G. Moreover, the authors analyzed functional differ-
ences between membrane-bound and soluble HLA-G. F.
Montespan et al. have demonstrated that human mesenchy-
mal stem cells derived from bone marrow or adipose tissue
maintain HLA-G expression and consequently retain their
immunoregulatory properties after osteodifferentiation, thus
suggesting that these cells may be used for bone repair.
Finally, E. Alegre et al. have analyzed HLA-G biochemistry
with special emphasis to the mechanisms that regulate its
expression and how the protein modifications affect the
quantification.
The role of HLA-G in pathological conditions is the key
topic of this special issue. M. Ezeakile et al. have demon-
strated that the presence of HLA-G dimers in kidney trans-
plant patients prolonged kidney allograft survival. L. Amiot
et al. have analyzed data regarding HLA-G expression in
patients with bacterial, viral, or parasitic infections, with
particular attention on factors released by parasites that may
affect HLA-G expression. Novel interesting data regarding
HLA-G expression and function in human tumors have been
described in two papers. G. Locafaro et al. have demonstrated
that HLA-G expressing DC-10 and CD4+ T cells are highly
represented in AML patients with HLA-G+ blasts and may
contribute to immune escape of tumor cells. In contrast, M. J.
Rutten et al. have demonstrated that HLA-G expression on
tumor cells in ovarian carcinoma patients is an independent
prognostic factor that predicts a better overall and event-free
survival and response to chemotherapy.
Finally, the expression and function of HLA-E have been
investigated by F. Morandi et al., whohave demonstrated that
IL-27 treatment upregulated HLA-E expression on human
monocytes, rendering the latter cells immunosuppressive,
through the inhibition of IFN-𝛾 secretion by NK cells.
In conclusion, the papers in this issue will help to enrich
the current knowledge regardingHLA-Ibmolecules and their
role in physiological and pathological conditions.
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